3M finalises $6.7 billion acquisition of Acelity

139

3M-Acelity-Acquisition

3M has announced that it has completed the acquisition of Acelity and its KCI subsidiaries from a consortium comprised of funds advised by Apax Partners (the Apax Funds), together with controlled affiliates of the Canada Pension Plan Investment Board (CPPIB) and the Public Sector Pension Investment Board (PSP Investments).

Acquired for a total enterprise value of approximately US$6.7 billion, including the assumption of debt and other adjustments, Acelity is a leading global medical technology company focused on advanced wound care and specialty surgical applications marketed under the KCI brand.

“This is an exciting day as we bring together two premier and innovative companies that are focused on delivering comprehensive health care solutions to enable better outcomes for patients,” said 3M chairman and CEO Mike Roman.

“We are excited to have the tremendous people of Acelity join the 3M team, and are confident in the value that this acquisition will deliver to our customers and our shareholders. This addition further accelerates 3M as a leader in advanced wound care, which is a significant and growing market segment.”

3M’s Medical Solutions business is said to be focused on applying 3M technologies to deliver safe and effective solutions to improve clinical outcomes and healthcare economics. The business also offers a range of integrated solutions that include advanced and acute wound care dressings and products, medical tapes, sterilisation products, and patient prep and warming products.

According to a statement, these solutions cross the entire continuum of care, enabling better outcomes, improving the patient experience, and delivering strong economic value in today’s value-based care environment.

The Acelity business is well known for creating and growing new segments based on the ability to identify and address unmet clinical needs with KCI-branded products that advance the practice of medicine, beginning with the introduction of V.A.C. Therapy: groundbreaking Negative Pressure Wound Therapy (NPWT). Furthermore, KCI product offerings also include advanced wound dressings and negative pressure surgical solutions.

LEAVE A REPLY

Please enter your comment!
Please enter your name here